BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31138282)

  • 21. Inhibition of the in vitro growth of Babesia bigemina, Babesia caballi and Theileria equi parasites by trifluralin analogues.
    G Silva M; Knowles DP; Antunes S; Domingos A; Esteves MA; Suarez CE
    Ticks Tick Borne Dis; 2017 Jun; 8(4):593-597. PubMed ID: 28416183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites.
    Rizk MA; El-Sayed SAE; AbouLaila M; Yokoyama N; Igarashi I
    Exp Parasitol; 2017 Aug; 179():43-48. PubMed ID: 28655583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the inhibitory effect of Zingiber officinale rhizome on Babesia and Theileria parasites.
    Rizk MA; El-Sayed SAE; Igarashi I
    Parasitol Int; 2021 Dec; 85():102431. PubMed ID: 34352378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-piroplasmic activity of novobiocin as heat shock protein 90 inhibitor against in vitro cultured Theileria equi and Babesia caballi parasites.
    Suthar A; Maji C; Gopalkrishnan A; Raval SH; Kumar R; Kumar S
    Ticks Tick Borne Dis; 2021 Jul; 12(4):101696. PubMed ID: 33677232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Effects of Atranorin towards the Proliferation of
    Beshbishy AM; Batiha GE; Alkazmi L; Nadwa E; Rashwan E; Abdeen A; Yokoyama N; Igarashi I
    Pathogens; 2020 Feb; 9(2):. PubMed ID: 32079149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiparasitic activity of FLLL-32 against four
    El-Sayed SAE; El-Alfy ES; Baghdadi HB; Sayed-Ahmed MZ; Alqahtani SS; Alam N; Ahmad S; Ali MS; Igarashi I; Rizk MA
    Front Pharmacol; 2023; 14():1278451. PubMed ID: 38027032
    [No Abstract]   [Full Text] [Related]  

  • 27. Ascorbic acid co-administration with a low dose of diminazene aceturate inhibits the in vitro growth of Theileria equi, and the in vivo growth of Babesia microti.
    Rizk MA; El-Sayed SAE; Igarashi I
    Parasitol Int; 2022 Oct; 90():102596. PubMed ID: 35533961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites.
    Nugraha AB; Tuvshintulga B; Guswanto A; Tayebwa DS; Rizk MA; Gantuya S; El-Saber Batiha G; Beshbishy AM; Sivakumar T; Yokoyama N; Igarashi I
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():84-90. PubMed ID: 31254719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clofazimine Inhibits the Growth of Babesia and Theileria Parasites In Vitro and In Vivo.
    Tuvshintulga B; AbouLaila M; Davaasuren B; Ishiyama A; Sivakumar T; Yokoyama N; Iwatsuki M; Otoguro K; Ōmura S; Igarashi I
    Antimicrob Agents Chemother; 2016 May; 60(5):2739-46. PubMed ID: 26883713
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Rizk MA; El-Sayed SAE; Igarashi I
    Pathog Glob Health; 2023 May; 117(3):315-321. PubMed ID: 36172647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lumefantrine and o-choline - Parasite metabolism specific drug molecules inhibited in vitro growth of Theileria equi and Babesia caballi in MASP culture system.
    Maji C; Goel P; Suthar A; Mandal KD; Gopalakrishnan A; Kumar R; Tripathi BN; Kumar S
    Ticks Tick Borne Dis; 2019 Apr; 10(3):568-574. PubMed ID: 30733146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review.
    Rizk MA; El-Sayed SAE; El-Khodery S; Yokoyama N; Igarashi I
    Vet Parasitol; 2019 Oct; 274():108895. PubMed ID: 31494399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites.
    Munkhjargal T; AbouLaila M; Terkawi MA; Sivakumar T; Ichikawa M; Davaasuren B; Nyamjargal T; Yokoyama N; Igarashi I
    Am J Trop Med Hyg; 2012 Oct; 87(4):681-8. PubMed ID: 22890034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Bioinformatics Analysis of Transcription Factor Genes Indicates Conservation of Key Regulatory Domains among Babesia bovis, Babesia microti, and Theileria equi.
    Alzan HF; Knowles DP; Suarez CE
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0004983. PubMed ID: 27832060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of terpene nerolidol on the growth of Babesia parasites.
    AbouLaila M; Sivakumar T; Yokoyama N; Igarashi I
    Parasitol Int; 2010 Jun; 59(2):278-82. PubMed ID: 20178862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imidazo[1,2-a]pyridine: a Highly Potent Therapeutic Agent Clears Piroplasm Infection In Vitro.
    Rizk MA; El-Sayed SAE; El-Alfy ES; Igarashi I
    Acta Parasitol; 2023 Mar; 68(1):249-256. PubMed ID: 36637693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the inhibitory effect of resveratrol on the multiplication of several
    El-Sayed SAE; El-Alfy ES; Sayed-Ahmed MZ; Mohanta UK; Alqahtani SS; Alam N; Ahmad S; Ali MS; Igarashi I; Rizk MA
    Front Pharmacol; 2023; 14():1192999. PubMed ID: 37324476
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of using pyronaridine tetraphosphate- based combination therapy in the treatment of babesiosis caused by Babesia bovis, B. caballi, and B. gibsoni in vitro and B. microti in mice.
    El-Sayed SAE; Rizk MA; Ringo AE; Li Y; Liu M; Ji S; Li J; Byamukama B; Tumwebaze MA; Xuan X; Igarashi I
    Parasitol Int; 2021 Apr; 81():102260. PubMed ID: 33264674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of methanolic extract from
    Rizk MA; El-Salam El-Sayed SA; Al-Araby M; Igarashi I
    Vet World; 2022 Jan; 15(1):76-82. PubMed ID: 35369597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo.
    Nehrbass-Stuedli A; Boykin D; Tidwell RR; Brun R
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3439-45. PubMed ID: 21537025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.